Side Effects of Antihypertensives Induced by Switching to Different Generic Medications: Case Reports.

Q4 Biochemistry, Genetics and Molecular Biology
Apichai Wattanapisit, Penpun Lertwatanachai, Thittita Pongsawat, Sanhapan Wattanapisit, Jaruporn Thongruch
{"title":"Side Effects of Antihypertensives Induced by Switching to Different Generic Medications: Case Reports.","authors":"Apichai Wattanapisit,&nbsp;Penpun Lertwatanachai,&nbsp;Thittita Pongsawat,&nbsp;Sanhapan Wattanapisit,&nbsp;Jaruporn Thongruch","doi":"10.14712/23362936.2023.13","DOIUrl":null,"url":null,"abstract":"<p><p>Generic medication is a product that contains the same active substance and pharmaceutical characteristics as brand-name medications. Generic medications are cost-effective and comparable to brand-name medications in terms of clinical endpoints. However, the use of generic medications instead of brand-name medications is a debatable issue among patients and healthcare providers. Two patients with essential hypertension experienced side effects after switching to different generic antihypertensives (one generic medication to another generic medication). Adverse drug reactions, including, hypersensitivity, side effects, and intolerance, should be identified through present and past medical history and clinical characteristics. The adverse drug reactions in both patients were more likely to be side effects of the medications after switching to different generic antihypertensives produced by different companies (patient 1: enalapril and patient 2: amlodipine). The side effects were possibly caused by the different inactive ingredients or excipients. These two case reports emphasise the importance of monitoring adverse drug reactions throughout the course of treatment and communicating with patients prior to switching to a new generic medication.</p>","PeriodicalId":35490,"journal":{"name":"Prague medical report","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Prague medical report","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14712/23362936.2023.13","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
引用次数: 0

Abstract

Generic medication is a product that contains the same active substance and pharmaceutical characteristics as brand-name medications. Generic medications are cost-effective and comparable to brand-name medications in terms of clinical endpoints. However, the use of generic medications instead of brand-name medications is a debatable issue among patients and healthcare providers. Two patients with essential hypertension experienced side effects after switching to different generic antihypertensives (one generic medication to another generic medication). Adverse drug reactions, including, hypersensitivity, side effects, and intolerance, should be identified through present and past medical history and clinical characteristics. The adverse drug reactions in both patients were more likely to be side effects of the medications after switching to different generic antihypertensives produced by different companies (patient 1: enalapril and patient 2: amlodipine). The side effects were possibly caused by the different inactive ingredients or excipients. These two case reports emphasise the importance of monitoring adverse drug reactions throughout the course of treatment and communicating with patients prior to switching to a new generic medication.

切换不同非专利药物引起的降压药副作用:病例报告。
仿制药是一种含有与品牌药相同的活性物质和药物特性的产品。仿制药具有成本效益,在临床终点方面与品牌药相当。然而,使用非专利药物代替品牌药物在患者和医疗保健提供者之间是一个有争议的问题。两名原发性高血压患者在切换到不同的通用抗高血压药物(一种通用药物到另一种通用药物)后出现了副作用。药物不良反应,包括过敏、副作用和不耐受,应通过现在和过去的病史和临床特征来确定。两例患者改用不同公司生产的不同仿制抗高血压药(患者1:依那普利,患者2:氨氯地平)后,药物不良反应更有可能是药物的副作用。副作用可能是由不同的非活性成分或赋形剂引起的。这两个病例报告强调了在整个治疗过程中监测药物不良反应以及在改用新的非专利药物之前与患者沟通的重要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Prague medical report
Prague medical report Medicine-Medicine (all)
CiteScore
1.10
自引率
0.00%
发文量
19
审稿时长
20 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信